Primary antimicrobial resistance of Helicobacter pylori in children during the past 9 years

Pediatrics International

Volumn 52, Issue 2, 2010, Pages 187-190

  Kato, Seiichi ^a,b   Fujimura, Shigeru ^b  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOHOKU UNIVERSITY   (Japan)

Author keywords

Antimicrobial resistance; Child; Clarithromycin; Helicobacter pylori; Metronidazole

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; LANSOPRAZOLE; METRONIDAZOLE; ANTIINFECTIVE AGENT;

ADOLESCENT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATION; BROTH DILUTION; CHILD; CONTROLLED STUDY; ERADICATION THERAPY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; MINIMUM INHIBITORY CONCENTRATION; PREVALENCE; PRIORITY JOURNAL; STOMACH BIOPSY; STRAIN DIFFERENCE; TREATMENT FAILURE; DRUG EFFECTS; PRESCHOOL CHILD; TIME;

ADOLESCENT; AMOXICILLIN; ANTI-INFECTIVE AGENTS; CHILD; CHILD, PRESCHOOL; CLARITHROMYCIN; DRUG RESISTANCE, BACTERIAL; HELICOBACTER PYLORI; HUMANS; METRONIDAZOLE; TIME FACTORS;

EID: 77950225013     PISSN: 13288067     EISSN: 1442200X     Source Type: Journal    
DOI: 10.1111/j.1442-200X.2009.02915.x     Document Type: Article

References (20)

1. Kato S, Nishino Y, Ozawa K et al. The prevalence of Helicobacter pylori in Japanese children with gastritis and peptic ulcer disease. J. Gastroenterol. 2004 39 : 734 738.
2. Uemura N, Okamoto S, Yamamoto S et al. Helicobacter pylori infection and the development of gastric cancer. N. Engl. J. Med. 2001 345 : 784 789.
3. Kato S, Nakajima S, Nishino Y et al. Association between gastric atrophy and Helicobacter pylori infection in Japanese children: A retrospective multicenter study. Dig. Dis. Sci. 2006 51 : 99 104.
4. Ricuarte O, Gutierrez O, Cardona H, Kim JG, Graham DY, El-Zimaity HM. Atrophic gastritis in young children and adolescents. J. Clin. Pathol. 2005 58 : 1189 1193.
5. DuBois S, Kearney D. Iron-deficiency anemia and Helicobacter pylori infection: A review of the evidence. Am. J. Gastroenterol. 2005 100 : 453 459.
6. Kato S, Konno M, Shimizu T et al. Guideline on diagnosis and management of childhood Helicobacter pylori infection (Japanese). J. Jpn Pediatr. Soc. 2005 109 : 1297 1300.
7. Gold BD, Colletti RB, Abbott M et al. Helicobacter pylori infection in children: Recommendations for diagnosis and treatment. J. Pediatr. Gastroenterol. Nutr. 2000 31 : 490 497.
8. Kato S, Ritsuno H, Ohnuma K, Iinuma K, Sugiyama T, Asaka M. Safety and efficacy of one-week triple therapy for eradicating Helicobacter pylori in children. Helicobacter 1998 3 : 278 282.
9. Kato S, Fujimura S, Udagawa H et al. Antibiotic resistance of Helicobacter pylori strains in Japanese children. J. Clin. Microbiol. 2002 40 : 649 653.
10. Lopez-Brea M, Martinez MJ, Domingo D, Alarcon T. A 9 year study of clarithromycin and metronidazole resistance in Helicobacter pylori from Spanish children. J. Antimicrob. Chemother. 2001 48 : 295 297.
11. Koletzko S, Richy F, Bontems P et al. Prospective multicentre study on antibiotic resistance of Helicobacter pylori strains obtained from children living in Europe. Gut 2006 55 : 1711 1716.
12. Kobayashi I, Murakami K, Kato M et al. Changing antimicrobial susceptibility epidemiology of Helicobacter pylori strains in Japan between 2002 and 2005. J. Clin. Microbiol. 2007 45 : 4006 4010.
13. 13C-urea breath test for childhood Helicobacter pylori infection: A multicenter Japanese study. Am. J. Gastroenterol. 2002 97 : 1668 1673.
14. Versalovic J, Osato MS, Spakovsky K et al. Point mutations in the 23S rRNA gene of Helicobacter pylori associated with different levels of clarithromycin resistance. J. Antimicrob. Chemother. 1997 40 : 283 286.
15. Fujimura S, Kato S, Kawamura T, Watanabe A. In vitro activity of rifampicin against Helicobacter pylori isolated from children and adults. J. Antimicrob. Chemother. 2002 49 : 541 543.
16. Megraud F. Epidemiology and mechanism of antibiotic resistance in Helicobacter pylori. Gastroenterology 1998 115 : 1278 1282.
17. Taneike I, Suzuki K, Nakagawa S, Yamamoto T. Intrafamilial spread of the same clarithromycin-resistant Helicobacter pylori infection confirmed by molecular analysis. J. Clin. Microbiol. 2004 42 : 3901 3903.
18. Miehlke S, Hansky K, Schneider-Brachert W et al. Randomized trial of rifabutin-based triple therapy and high-dose dual therapy for rescue treatment of Helicobacter pylori resistant to both metronidazole and clarithromycin. Aliment. Pharmacol. Ther. 2006 24 : 395 403.
19. Graham DY. Antibiotic resistance in Helicobacter pylori: Implications for therapy. Gastroenterology 1998 115 : 1272 1277.
20. Fuccio L, Minardi ME, Zagari RM, Grilli D, Magrini N, Bazzoli F. Meta-analysis: Duration of first-line proton-pump inhibitor based triple therapy for Helicobacter pylori eradication. Ann. Intern. Med. 2007 147 : 553 562.